Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001048477-05-000017
Filing Date
2005-02-11
Accepted
2005-02-11 14:33:34
Documents
1
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 urquhart_form5021005ex.html 5  
1 urquhart_form5021005ex.xml 5 3963
  Complete submission text file 0001048477-05-000017.txt   5696
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INVERESK RESEARCH GROUP, INC. 11000 WESTON PARKWAY, SUITE 100 CARY NC 27513
Business Address
URQUHART JOHN (Reporting) CIK: 0001226495 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-26727 | Film No.: 05597388